Table of Content

1 Study Coverage
1.1 Meningococcal Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Disease Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injectable
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Meningococcal Disease Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Meningococcal Disease Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Meningococcal Disease Drugs Revenue by Region
2.2.1 Global Meningococcal Disease Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Meningococcal Disease Drugs Revenue by Region (2018-2024)
2.2.3 Global Meningococcal Disease Drugs Revenue by Region (2024-2029)
2.2.4 Global Meningococcal Disease Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Meningococcal Disease Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Meningococcal Disease Drugs Sales by Region
2.4.1 Global Meningococcal Disease Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Meningococcal Disease Drugs Sales by Region (2018-2024)
2.4.3 Global Meningococcal Disease Drugs Sales by Region (2024-2029)
2.4.4 Global Meningococcal Disease Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Meningococcal Disease Drugs Sales by Manufacturers
3.1.1 Global Meningococcal Disease Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Meningococcal Disease Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningococcal Disease Drugs in 2022
3.2 Global Meningococcal Disease Drugs Revenue by Manufacturers
3.2.1 Global Meningococcal Disease Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Meningococcal Disease Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Disease Drugs Revenue in 2022
3.3 Global Key Players of Meningococcal Disease Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Meningococcal Disease Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Meningococcal Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Meningococcal Disease Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Meningococcal Disease Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Meningococcal Disease Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meningococcal Disease Drugs Sales by Type
4.1.1 Global Meningococcal Disease Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Meningococcal Disease Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Meningococcal Disease Drugs Sales Market Share by Type (2018-2029)
4.2 Global Meningococcal Disease Drugs Revenue by Type
4.2.1 Global Meningococcal Disease Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Meningococcal Disease Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Meningococcal Disease Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Meningococcal Disease Drugs Price by Type
4.3.1 Global Meningococcal Disease Drugs Price by Type (2018-2024)
4.3.2 Global Meningococcal Disease Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Meningococcal Disease Drugs Sales by Application
5.1.1 Global Meningococcal Disease Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Meningococcal Disease Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Meningococcal Disease Drugs Sales Market Share by Application (2018-2029)
5.2 Global Meningococcal Disease Drugs Revenue by Application
5.2.1 Global Meningococcal Disease Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Meningococcal Disease Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Meningococcal Disease Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Meningococcal Disease Drugs Price by Application
5.3.1 Global Meningococcal Disease Drugs Price by Application (2018-2024)
5.3.2 Global Meningococcal Disease Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Meningococcal Disease Drugs Market Size by Type
6.1.1 US & Canada Meningococcal Disease Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Meningococcal Disease Drugs Revenue by Type (2018-2029)
6.2 US & Canada Meningococcal Disease Drugs Market Size by Application
6.2.1 US & Canada Meningococcal Disease Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Meningococcal Disease Drugs Revenue by Application (2018-2029)
6.3 US & Canada Meningococcal Disease Drugs Market Size by Country
6.3.1 US & Canada Meningococcal Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Meningococcal Disease Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Meningococcal Disease Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Meningococcal Disease Drugs Market Size by Type
7.1.1 Europe Meningococcal Disease Drugs Sales by Type (2018-2029)
7.1.2 Europe Meningococcal Disease Drugs Revenue by Type (2018-2029)
7.2 Europe Meningococcal Disease Drugs Market Size by Application
7.2.1 Europe Meningococcal Disease Drugs Sales by Application (2018-2029)
7.2.2 Europe Meningococcal Disease Drugs Revenue by Application (2018-2029)
7.3 Europe Meningococcal Disease Drugs Market Size by Country
7.3.1 Europe Meningococcal Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Meningococcal Disease Drugs Sales by Country (2018-2029)
7.3.3 Europe Meningococcal Disease Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Meningococcal Disease Drugs Market Size
8.1.1 China Meningococcal Disease Drugs Sales (2018-2029)
8.1.2 China Meningococcal Disease Drugs Revenue (2018-2029)
8.2 China Meningococcal Disease Drugs Market Size by Application
8.2.1 China Meningococcal Disease Drugs Sales by Application (2018-2029)
8.2.2 China Meningococcal Disease Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Meningococcal Disease Drugs Market Size by Type
9.1.1 Asia Meningococcal Disease Drugs Sales by Type (2018-2029)
9.1.2 Asia Meningococcal Disease Drugs Revenue by Type (2018-2029)
9.2 Asia Meningococcal Disease Drugs Market Size by Application
9.2.1 Asia Meningococcal Disease Drugs Sales by Application (2018-2029)
9.2.2 Asia Meningococcal Disease Drugs Revenue by Application (2018-2029)
9.3 Asia Meningococcal Disease Drugs Sales by Region
9.3.1 Asia Meningococcal Disease Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Meningococcal Disease Drugs Revenue by Region (2018-2029)
9.3.3 Asia Meningococcal Disease Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Meningococcal Disease Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Meningococcal Disease Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 GlaxoSmithKline Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Pasteur Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Merck Sharp & Dohme
11.5.1 Merck Sharp & Dohme Company Information
11.5.2 Merck Sharp & Dohme Overview
11.5.3 Merck Sharp & Dohme Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Merck Sharp & Dohme Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Sharp & Dohme Recent Developments
11.6 Hebei Hejia Pharmaceutical Technology Group Co., Ltd
11.6.1 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Company Information
11.6.2 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Overview
11.6.3 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Recent Developments
11.7 Shandong Jincheng Pharmaceutical Group Co.,ltd.
11.7.1 Shandong Jincheng Pharmaceutical Group Co.,ltd. Company Information
11.7.2 Shandong Jincheng Pharmaceutical Group Co.,ltd. Overview
11.7.3 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shandong Jincheng Pharmaceutical Group Co.,ltd. Recent Developments
11.8 Apeloa Pharmaceutical Co.,Ltd.
11.8.1 Apeloa Pharmaceutical Co.,Ltd. Company Information
11.8.2 Apeloa Pharmaceutical Co.,Ltd. Overview
11.8.3 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Apeloa Pharmaceutical Co.,Ltd. Recent Developments
11.9 Yiling Pharmaceutical
11.9.1 Yiling Pharmaceutical Company Information
11.9.2 Yiling Pharmaceutical Overview
11.9.3 Yiling Pharmaceutical Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Yiling Pharmaceutical Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yiling Pharmaceutical Recent Developments
11.10 Baiyunshan Pharmaceutical
11.10.1 Baiyunshan Pharmaceutical Company Information
11.10.2 Baiyunshan Pharmaceutical Overview
11.10.3 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Baiyunshan Pharmaceutical Recent Developments
11.11 SSY Group Limited
11.11.1 SSY Group Limited Company Information
11.11.2 SSY Group Limited Overview
11.11.3 SSY Group Limited Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 SSY Group Limited Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 SSY Group Limited Recent Developments
11.12 Lukang Pharmaceutical Co.,Ltd.
11.12.1 Lukang Pharmaceutical Co.,Ltd. Company Information
11.12.2 Lukang Pharmaceutical Co.,Ltd. Overview
11.12.3 Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Lukang Pharmaceutical Co.,Ltd. Recent Developments
11.13 North China Pharmaceutical Company Ltd.
11.13.1 North China Pharmaceutical Company Ltd. Company Information
11.13.2 North China Pharmaceutical Company Ltd. Overview
11.13.3 North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 North China Pharmaceutical Company Ltd. Recent Developments
11.14 Harbin Pharmaceutical Group Co.,Ltd.
11.14.1 Harbin Pharmaceutical Group Co.,Ltd. Company Information
11.14.2 Harbin Pharmaceutical Group Co.,Ltd. Overview
11.14.3 Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Harbin Pharmaceutical Group Co.,Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meningococcal Disease Drugs Industry Chain Analysis
12.2 Meningococcal Disease Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningococcal Disease Drugs Production Mode & Process
12.4 Meningococcal Disease Drugs Sales and Marketing
12.4.1 Meningococcal Disease Drugs Sales Channels
12.4.2 Meningococcal Disease Drugs Distributors
12.5 Meningococcal Disease Drugs Customers
13 Market Dynamics
13.1 Meningococcal Disease Drugs Industry Trends
13.2 Meningococcal Disease Drugs Market Drivers
13.3 Meningococcal Disease Drugs Market Challenges
13.4 Meningococcal Disease Drugs Market Restraints
14 Key Findings in The Global Meningococcal Disease Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Meningococcal Disease Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Injectable
Table 3. Major Manufacturers of Oral
Table 4. Global Meningococcal Disease Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Meningococcal Disease Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Meningococcal Disease Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Meningococcal Disease Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Meningococcal Disease Drugs Revenue Market Share by Region (2018-2024)
Table 9. Global Meningococcal Disease Drugs Revenue Market Share by Region (2024-2029)
Table 10. Global Meningococcal Disease Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Meningococcal Disease Drugs Sales by Region (2018-2024) & (Kiloton)
Table 12. Global Meningococcal Disease Drugs Sales by Region (2024-2029) & (Kiloton)
Table 13. Global Meningococcal Disease Drugs Sales Market Share by Region (2018-2024)
Table 14. Global Meningococcal Disease Drugs Sales Market Share by Region (2024-2029)
Table 15. Global Meningococcal Disease Drugs Sales by Manufacturers (2018-2024) & (Kiloton)
Table 16. Global Meningococcal Disease Drugs Sales Share by Manufacturers (2018-2024)
Table 17. Global Meningococcal Disease Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Meningococcal Disease Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Meningococcal Disease Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Meningococcal Disease Drugs Price by Manufacturers 2018-2024 (US$/Ton)
Table 21. Global Meningococcal Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Meningococcal Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Disease Drugs as of 2022)
Table 23. Global Key Manufacturers of Meningococcal Disease Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Meningococcal Disease Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Meningococcal Disease Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Meningococcal Disease Drugs Sales by Type (2018-2024) & (Kiloton)
Table 28. Global Meningococcal Disease Drugs Sales by Type (2024-2029) & (Kiloton)
Table 29. Global Meningococcal Disease Drugs Sales Share by Type (2018-2024)
Table 30. Global Meningococcal Disease Drugs Sales Share by Type (2024-2029)
Table 31. Global Meningococcal Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Meningococcal Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Meningococcal Disease Drugs Revenue Share by Type (2018-2024)
Table 34. Global Meningococcal Disease Drugs Revenue Share by Type (2024-2029)
Table 35. Meningococcal Disease Drugs Price by Type (2018-2024) & (US$/Ton)
Table 36. Global Meningococcal Disease Drugs Price Forecast by Type (2024-2029) & (US$/Ton)
Table 37. Global Meningococcal Disease Drugs Sales by Application (2018-2024) & (Kiloton)
Table 38. Global Meningococcal Disease Drugs Sales by Application (2024-2029) & (Kiloton)
Table 39. Global Meningococcal Disease Drugs Sales Share by Application (2018-2024)
Table 40. Global Meningococcal Disease Drugs Sales Share by Application (2024-2029)
Table 41. Global Meningococcal Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Meningococcal Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Meningococcal Disease Drugs Revenue Share by Application (2018-2024)
Table 44. Global Meningococcal Disease Drugs Revenue Share by Application (2024-2029)
Table 45. Meningococcal Disease Drugs Price by Application (2018-2024) & (US$/Ton)
Table 46. Global Meningococcal Disease Drugs Price Forecast by Application (2024-2029) & (US$/Ton)
Table 47. US & Canada Meningococcal Disease Drugs Sales by Type (2018-2024) & (Kiloton)
Table 48. US & Canada Meningococcal Disease Drugs Sales by Type (2024-2029) & (Kiloton)
Table 49. US & Canada Meningococcal Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Meningococcal Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Meningococcal Disease Drugs Sales by Application (2018-2024) & (Kiloton)
Table 52. US & Canada Meningococcal Disease Drugs Sales by Application (2024-2029) & (Kiloton)
Table 53. US & Canada Meningococcal Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Meningococcal Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Meningococcal Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Meningococcal Disease Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Meningococcal Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Meningococcal Disease Drugs Sales by Country (2018-2024) & (Kiloton)
Table 59. US & Canada Meningococcal Disease Drugs Sales by Country (2024-2029) & (Kiloton)
Table 60. Europe Meningococcal Disease Drugs Sales by Type (2018-2024) & (Kiloton)
Table 61. Europe Meningococcal Disease Drugs Sales by Type (2024-2029) & (Kiloton)
Table 62. Europe Meningococcal Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Meningococcal Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Meningococcal Disease Drugs Sales by Application (2018-2024) & (Kiloton)
Table 65. Europe Meningococcal Disease Drugs Sales by Application (2024-2029) & (Kiloton)
Table 66. Europe Meningococcal Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Meningococcal Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Meningococcal Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Meningococcal Disease Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Meningococcal Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Meningococcal Disease Drugs Sales by Country (2018-2024) & (Kiloton)
Table 72. Europe Meningococcal Disease Drugs Sales by Country (2024-2029) & (Kiloton)
Table 73. China Meningococcal Disease Drugs Sales by Type (2018-2024) & (Kiloton)
Table 74. China Meningococcal Disease Drugs Sales by Type (2024-2029) & (Kiloton)
Table 75. China Meningococcal Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Meningococcal Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Meningococcal Disease Drugs Sales by Application (2018-2024) & (Kiloton)
Table 78. China Meningococcal Disease Drugs Sales by Application (2024-2029) & (Kiloton)
Table 79. China Meningococcal Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Meningococcal Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Meningococcal Disease Drugs Sales by Type (2018-2024) & (Kiloton)
Table 82. Asia Meningococcal Disease Drugs Sales by Type (2024-2029) & (Kiloton)
Table 83. Asia Meningococcal Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Meningococcal Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Meningococcal Disease Drugs Sales by Application (2018-2024) & (Kiloton)
Table 86. Asia Meningococcal Disease Drugs Sales by Application (2024-2029) & (Kiloton)
Table 87. Asia Meningococcal Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Meningococcal Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Meningococcal Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Meningococcal Disease Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Meningococcal Disease Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Meningococcal Disease Drugs Sales by Region (2018-2024) & (Kiloton)
Table 93. Asia Meningococcal Disease Drugs Sales by Region (2024-2029) & (Kiloton)
Table 94. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Type (2018-2024) & (Kiloton)
Table 95. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Type (2024-2029) & (Kiloton)
Table 96. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Application (2018-2024) & (Kiloton)
Table 99. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Application (2024-2029) & (Kiloton)
Table 100. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Country (2018-2024) & (Kiloton)
Table 106. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales by Country (2024-2029) & (Kiloton)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 110. Pfizer Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. GlaxoSmithKline Company Information
Table 113. GlaxoSmithKline Description and Major Businesses
Table 114. GlaxoSmithKline Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 115. GlaxoSmithKline Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GlaxoSmithKline Recent Developments
Table 117. Sanofi Pasteur Company Information
Table 118. Sanofi Pasteur Description and Major Businesses
Table 119. Sanofi Pasteur Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 120. Sanofi Pasteur Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Pasteur Recent Developments
Table 122. Novartis Company Information
Table 123. Novartis Description and Major Businesses
Table 124. Novartis Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 125. Novartis Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novartis Recent Developments
Table 127. Merck Sharp & Dohme Company Information
Table 128. Merck Sharp & Dohme Description and Major Businesses
Table 129. Merck Sharp & Dohme Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 130. Merck Sharp & Dohme Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Merck Sharp & Dohme Recent Developments
Table 132. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Company Information
Table 133. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Description and Major Businesses
Table 134. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 135. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Recent Developments
Table 137. Shandong Jincheng Pharmaceutical Group Co.,ltd. Company Information
Table 138. Shandong Jincheng Pharmaceutical Group Co.,ltd. Description and Major Businesses
Table 139. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 140. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Shandong Jincheng Pharmaceutical Group Co.,ltd. Recent Developments
Table 142. Apeloa Pharmaceutical Co.,Ltd. Company Information
Table 143. Apeloa Pharmaceutical Co.,Ltd. Description and Major Businesses
Table 144. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 145. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Apeloa Pharmaceutical Co.,Ltd. Recent Developments
Table 147. Yiling Pharmaceutical Company Information
Table 148. Yiling Pharmaceutical Description and Major Businesses
Table 149. Yiling Pharmaceutical Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 150. Yiling Pharmaceutical Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Yiling Pharmaceutical Recent Developments
Table 152. Baiyunshan Pharmaceutical Company Information
Table 153. Baiyunshan Pharmaceutical Description and Major Businesses
Table 154. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 155. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Baiyunshan Pharmaceutical Recent Developments
Table 157. SSY Group Limited Company Information
Table 158. SSY Group Limited Description and Major Businesses
Table 159. SSY Group Limited Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 160. SSY Group Limited Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. SSY Group Limited Recent Developments
Table 162. Lukang Pharmaceutical Co.,Ltd. Company Information
Table 163. Lukang Pharmaceutical Co.,Ltd. Description and Major Businesses
Table 164. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 165. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Lukang Pharmaceutical Co.,Ltd. Recent Developments
Table 167. North China Pharmaceutical Company Ltd. Company Information
Table 168. North China Pharmaceutical Company Ltd. Description and Major Businesses
Table 169. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 170. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. North China Pharmaceutical Company Ltd. Recent Developments
Table 172. Harbin Pharmaceutical Group Co.,Ltd. Company Information
Table 173. Harbin Pharmaceutical Group Co.,Ltd. Description and Major Businesses
Table 174. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 175. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Harbin Pharmaceutical Group Co.,Ltd. Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Meningococcal Disease Drugs Distributors List
Table 180. Meningococcal Disease Drugs Customers List
Table 181. Meningococcal Disease Drugs Market Trends
Table 182. Meningococcal Disease Drugs Market Drivers
Table 183. Meningococcal Disease Drugs Market Challenges
Table 184. Meningococcal Disease Drugs Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Disease Drugs Product Picture
Figure 2. Global Meningococcal Disease Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Meningococcal Disease Drugs Market Share by Type in 2022 & 2029
Figure 4. Injectable Product Picture
Figure 5. Oral Product Picture
Figure 6. Global Meningococcal Disease Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Meningococcal Disease Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Drugstores
Figure 10. Others
Figure 11. Meningococcal Disease Drugs Report Years Considered
Figure 12. Global Meningococcal Disease Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Meningococcal Disease Drugs Revenue 2018-2029 (US$ Million)
Figure 14. Global Meningococcal Disease Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Meningococcal Disease Drugs Revenue Market Share by Region (2018-2029)
Figure 16. Global Meningococcal Disease Drugs Sales 2018-2029 ((Kiloton)
Figure 17. Global Meningococcal Disease Drugs Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Meningococcal Disease Drugs Sales YoY (2018-2029) & (Kiloton)
Figure 19. US & Canada Meningococcal Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Meningococcal Disease Drugs Sales YoY (2018-2029) & (Kiloton)
Figure 21. Europe Meningococcal Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Meningococcal Disease Drugs Sales YoY (2018-2029) & (Kiloton)
Figure 23. China Meningococcal Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Meningococcal Disease Drugs Sales YoY (2018-2029) & (Kiloton)
Figure 25. Asia (excluding China) Meningococcal Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales YoY (2018-2029) & (Kiloton)
Figure 27. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Meningococcal Disease Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Meningococcal Disease Drugs in the World: Market Share by Meningococcal Disease Drugs Revenue in 2022
Figure 30. Global Meningococcal Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Meningococcal Disease Drugs Sales Market Share by Type (2018-2029)
Figure 32. Global Meningococcal Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 33. Global Meningococcal Disease Drugs Sales Market Share by Application (2018-2029)
Figure 34. Global Meningococcal Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Meningococcal Disease Drugs Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Meningococcal Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Meningococcal Disease Drugs Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Meningococcal Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Meningococcal Disease Drugs Revenue Share by Country (2018-2029)
Figure 40. US & Canada Meningococcal Disease Drugs Sales Share by Country (2018-2029)
Figure 41. U.S. Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Meningococcal Disease Drugs Sales Market Share by Type (2018-2029)
Figure 44. Europe Meningococcal Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 45. Europe Meningococcal Disease Drugs Sales Market Share by Application (2018-2029)
Figure 46. Europe Meningococcal Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 47. Europe Meningococcal Disease Drugs Revenue Share by Country (2018-2029)
Figure 48. Europe Meningococcal Disease Drugs Sales Share by Country (2018-2029)
Figure 49. Germany Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. France Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. China Meningococcal Disease Drugs Sales Market Share by Type (2018-2029)
Figure 55. China Meningococcal Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 56. China Meningococcal Disease Drugs Sales Market Share by Application (2018-2029)
Figure 57. China Meningococcal Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 58. Asia Meningococcal Disease Drugs Sales Market Share by Type (2018-2029)
Figure 59. Asia Meningococcal Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 60. Asia Meningococcal Disease Drugs Sales Market Share by Application (2018-2029)
Figure 61. Asia Meningococcal Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 62. Asia Meningococcal Disease Drugs Revenue Share by Region (2018-2029)
Figure 63. Asia Meningococcal Disease Drugs Sales Share by Region (2018-2029)
Figure 64. Japan Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. India Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Meningococcal Disease Drugs Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Meningococcal Disease Drugs Sales Share by Country (2018-2029)
Figure 75. Brazil Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Meningococcal Disease Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Meningococcal Disease Drugs Value Chain
Figure 81. Meningococcal Disease Drugs Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed